StockNow
Log in
U.S. Markets

Hims & Hers Health (HIMS) says it has begun offering branded GLP-1 weight-loss drugs and other treatments to men in Australia as it continues to expand its international business

StockNow breaking-news AI analysis

Hims & Hers Health has launched branded GLP-1 weight-loss drugs and men's treatments in Australia, continuing its international expansion following its acquisition deal with Australian digital health provider Eucalyptus.

1 stocks
HIMSHims & Hers Health, Inc.$29.65Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US President Trump weighing limited strikes against Iran, Axios reports

Geopolitics

US President Trump says Iran strikes will be limited; Strait of Hormuz is in extremely good shape; A lot of oil coming out of Hormuz; Ships came through Hormuz last night with Navy assist

U.S. Markets

Apple's (AAPL) Phil Schiller steps down from running App Store and Events, reports Bloomberg TV

AAPL